Form 8.3 - Abbvie Inc
October 25 2019 - 11:10AM
Dow Jones News
TIDM0QCV
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 24(th) October 2019
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 68,651,353 4.64231%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 68,651,353 4.64231%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 1,400 76.80
-------------- ----------------------------- -----------------------
Purchase 100 76.68
-------------- ----------------------------- -----------------------
Purchase 600 76.80
-------------- ----------------------------- -----------------------
Purchase 300 76.80
-------------- ----------------------------- -----------------------
Purchase 30,158 76.80
-------------- ----------------------------- -----------------------
Purchase 11,874 76.80
-------------- ----------------------------- -----------------------
Purchase 297 76.80
-------------- ----------------------------- -----------------------
Purchase 10,362 76.80
-------------- ----------------------------- -----------------------
Purchase 9,420 76.80
-------------- ----------------------------- -----------------------
Sale 600 76.80
-------------- ----------------------------- -----------------------
Sale 1,377 76.80
-------------- ----------------------------- -----------------------
Sale 1,400 76.80
-------------- ----------------------------- -----------------------
Sale 300 76.80
-------------- ----------------------------- -----------------------
Sale 600 76.80
-------------- ----------------------------- -----------------------
Sale 10,700 76.80
-------------- ----------------------------- -----------------------
Sale 1,319 76.80
-------------- ----------------------------- -----------------------
Sale 559 76.80
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -------------------
Date of disclosure 25(th) October 2019
------------------------------------------------------- -------------------
Contact name Lionel Colaco
------------------------------------------------------- -------------------
Telephone number 020 33956098
------------------------------------------------------- -------------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -------------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -------------------
(END) Dow Jones Newswires
October 25, 2019 10:55 ET (14:55 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jun 2024 to Jul 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Jul 2023 to Jul 2024
